What is driving this stock ?...It seem like more than excellent scientific progress....whatever is behind, I will take all up days..My naked PUTs are all far from danger zone now....Thinking of going after $120 or 130 Dec or Jan PUT sell....
Just wanted to isolate one theme: several of those drug combination results were in the "This sh.t just doesn't happen" range. Clinical results are NEVER as good as the models, but entire drug families grow out of results that good.
check out SGEN's news from yesterday. I am long that stock as well & think it is poised to breakout over the $40 resistance given improving fundamentals.
crazy thought, but maybe INCY tries to buy them? i'd guess they would have to pay close to $60 per share to get the deal done.
I hope they warned key people what was coming, but from the small number of questions I'm guessing not. No way would I have called that an investor presentation.
Very impressive technical presentation indeed. I had an internet burp near the end and missed some of the talk about how they'll go forward, but I'd guess that priority will go to the fastest likely paths to market. AML, while rare, has subtypes that have horrible prognosis. Second-line AML is probably licensable based on a very good p2. Myeloma is more common (still rare) and generally has a fairly benign prognosis today, but the treatments are brutal (to get decent 5-year survival, lethal marrow ablation with stem cell rescue is pretty much mandatory). There's a good patient organization which might be helpful. Long survival with periodic relapses is a good pattern for supplying trial subjects, but not so good for generating dramatic results. Still, probably fairly fast to market.
But more than ever, I see a huge clinical trial program that will be difficult to support with the income I can see. Since the company is heading toward a cancer focus, maybe sell its piece of the Baricitinib business--in installments, to avoid having unusable amounts of cash on hand.
i am with you....Huber was very professional and now the doc from Penn.....Would like to know who is in the room....most likely other docs.
No shares for sale @ $106.00------buy a few @ $126.00---?
Sentiment: Strong Buy
Bought INCY -3 years ago -lots of calls - calls gone --bought more @115------want to see a 10- $20.00 dollar -one day move- ISIS -AMGN my rockets---
Sentiment: Strong Buy